Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Manuel Llobet Insider Profile
4 Followers
Manuel Llobet, Chief Executive Officer at Allergy Therapeutics, holds 5.00M shares in Allergy Therapeutics (Ticker: GB:AGY).
Manuel Llobet Allergy Therapeutics (AGY)Chief Executive Officer
Allergy Therapeutics (AGY)
Chief Executive Officer
Ranked #34,159 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+11.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Executive Officer
Roles that Manuel Llobet holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 26, 2016 - Sep 26, 2017
Return:+90.70%
The most profitable trade made by Manuel Llobet
Manuel Llobet's Trading History
List of latest transactions for each holding click on a transaction to see Manuel Llobet's performance on stock
You May Also Like
Manuel Llobet insider profile FAQ
What is the percentage of profitable transactions made by Manuel Llobet?
The percentage of profitable transactions made by Manuel Llobet is 33%.
What is the average return per transaction made by Manuel Llobet?
The average return per transaction made by Manuel Llobet is 11.00%.
What stocks does Manuel Llobet hold?
Manuel Llobet holds: GB:AGY stocks.
What was Manuel Llobet’s latest transaction?
Manuel Llobet latest transaction was an Uninformative Sell of ―.
What was Manuel Llobet's most profitable transaction?
Manuel Llobet’s most profitable transaction was an Informative Buy of GB:AGY stock on September 26, 2016. The return on the trade was 90.70%.
What is Manuel Llobet's role in Allergy Therapeutics?
Manuel Llobet's role in Allergy Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.